COST-SAVING OF PHARMACIST INTERVENTION ON WARFARIN THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES.

Author(s)

siriluck Rojsutee, BSc(pharm), student1, paninchisa Musikachai, Bsc(pharm), student2, Petcharat Pongchareonsuk, PhD, Associate Professor3, Usa Chaikledkaew, PhD, Faculty member41mahidol university, bangkok 10400, Thailand; 2 mahidol university, Bangkok, Thailand; 3 Mahidol University, Payathai, Bangkok, Thailand; 4 Mahidol University, Bangkok, Thailand

OBJECTIVE: To evaluate the cost-saving of pharmacist intervention on warfarin therapy in Thai patients with mechanical heart valves from provider perspective. METHODS: Decision tree model was used to estimate the cost saving of pharmacist intervention on warfarin therapy. Only direct cost was used in the simulations. Estimates were based on the studyevaluating the impact of education and counseling by clinical pharmacists on anticoagulation therapy in patients with mechanical heart valves of Siriraj Hospital cost data were obtained from Siriraj Hospital. RESULTS: The mode estimates that pharmacist intervention can save cost on warfarin therapy in Thai patients with mechanical heart valves 12,049.89 baht ( $301.25 ) per patient per year (3,313,172.43 baht ( $82829.31 ) for total per year) CONCLUSIONS: Pharmacist intervention can provide substantial saving and present a favorable economic profile in the treatment of warfarin therapy in Thai patients with mechanical heart valves

Conference/Value in Health Info

2006-03, ISPOR Asia Pacific 2006, Shanghai, China

Code

PCV13

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Cardiovascular Disorders, Surgery

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×